English

Amgen (AMGN) · 2026-10-26 · Daily technical & news analysis

Amgen (AMGN) Technical Analysis — Chart, Levels & News

AMGN Daily Market Briefing and Technical Read — 2026-10-26

Published Oct 27, 2026 ET · Updated Oct 27, 2026 ET · Stocks & ETFs

Information only. This page covers charts, levels, and news for context, not financial or trading advice.

Automated draft. Levels and signals are rules-based and use completed bars.

S&P 500 context: SPY +0.69% on 2026-10-26; this ticker +1.22% in the same completed session.

At a glance

Amgen is above its 20-day (422.64), 50-day (417.85), and 200-day (372.18) averages. The trend reads up.

A typical day has moved about +2.50%% recently.

Support below: 433.42 | 422.64 | 413.44

Resistance above: Not enough completed bars for reliable levels.

What changed since the last close

Based on the completed 2026-10-26 session

More Healthcare tickers ETF coverage

Signal — short-term technical (daily chart)

On the daily horizon, AMGN maintains a bullish technical bias characterized by strong upside momentum and an established uptrend. A spinning top candlestick pattern was detected on the latest completed bar, serving strictly as short-term timing context for potential consolidation rather than a standalone directional signal.

News, Macro & Industry Context

The medium-term news sentiment is moderately bullish, underscored by positive analyst target revisions, growing institutional share acquisitions, and strong clinical pipeline visibility. Oppenheimer recently raised its target for Amgen stock from USD 450.00 to USD 480.00 following a positive 58 percent result report. Meanwhile, Apollon Wealth Management LLC grew its position in shares of Amgen Inc. by 10.2% in the third quarter. Amgen also announced the appointment of David W. Gibbs to its Board of Directors, adding experienced leadership to its Audit Committee and Compensation and Management Development Committee. Broader industry developments highlighted Amgen's unprecedented data at ESMO '26 alongside ongoing clinical discussions. From a macro perspective, the broader market operates in a range-bound environment characterized by sector rotation and investor caution regarding borrowing costs and capital expenditures. Bond markets continue to reflect elevated high-yield spreads and debt concerns, while safe-haven flows support a resilient US dollar against a backdrop of global yield pressures.

Catalysts

Amgen is scheduled to release its Q3 2026 earnings report after the market closes on Tuesday, November 3, 2026, representing the primary upcoming event-driven catalyst.

Levels & Risk

Key support levels are anchored by Fair Value Gaps ranging from 434.51 to 434.53, 420.35 to 433.42, 411.84 to 413.44, 394.50 to 404.34, and 386.50 to 398.52, alongside the Volume Area Low at 324.77 and VP POC at 348.02. Resistance is located at the Volume Area High of 387.88. Risk framing centres on the possibility of a pullback given deeply overbought conditions and the spinning top pattern, requiring disciplined risk management ahead of the upcoming earnings release.

Technical Breakdown

  • WaveTrend: bullish momentum (fast above slow), deeply overbought (fade zone)
  • SMI: bearish (below signal), overbought
  • Trend: price above EMA20 (uptrend bias); EMA5 above EMA13 (short-term bullish)
  • Triggers: no fresh trigger bars
  • Candlestick pattern: spinning top (detected on the latest completed bar)
  • Higher timeframe: no higher-timeframe extreme

2026-10-26 Daily brief

AMGN is covered in the 2026-10-26 Daily brief. Read the 2026-10-26 brief.

Learn the chart

Start with the question you have, not a trading strategy. Each guide explains one part of a ticker page in plain language.

All guides

Educational technical analysis. Not financial advice. Market data may be delayed or incomplete.